U01FD006807
Cooperative Agreement
Overview
Grant Description
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Washington,
District Of Columbia
200042401
United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/24 to 11/30/24 and the total obligations have increased 408% from $687,875 to $3,493,089.
Duke University was awarded
Cooperative Agreement U01FD006807
worth $3,493,089
from Center for Drug Evaluation and Research in September 2019 with work to be completed primarily in Washington District Of Columbia United States.
The grant
has a duration of 5 years 2 months and
was awarded through assistance program 93.103 Food and Drug Administration Research.
The Cooperative Agreement was awarded through grant opportunity Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities. (U01) Clinical Trial Not Allowed.
Status
(Complete)
Last Modified 8/20/24
Period of Performance
9/1/19
Start Date
11/30/24
End Date
Funding Split
$3.5M
Federal Obligation
$0.0
Non-Federal Obligation
$3.5M
Total Obligated
Activity Timeline
Transaction History
Modifications to U01FD006807
Additional Detail
Award ID FAIN
U01FD006807
SAI Number
U01FD006807-4234132369
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75FDA1 FDA OFFICE OF ACQUISITIONS AND GRANTS SERVICES
Funding Office
75DKKN FDA CENTER FOR DRUG EVALUATION AND RESEARCH
Awardee UEI
TP7EK8DZV6N5
Awardee CAGE
4B478
Performance District
DC-98
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) | Consumer and occupational health and safety | Grants, subsidies, and contributions (41.0) | $2,477,000 | 84% |
| FDA Innovation, CURES Act, Food and Drug Administration, Health and Human Services (075-5629) | Consumer and occupational health and safety | Grants, subsidies, and contributions (41.0) | $467,283 | 16% |
Modified: 8/20/24